The Latest Breaking News from HUM

Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Can it not?

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Some weaker-than-expected earnings are weighing on technology stocks. Super Micro Computer is down more...

Humana is scheduled to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings fall.

Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday, even as Washington's shutdown dragged into its third day.

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

While Humana has notably underperformed the broader healthcare sector over the past year, it has outperformed recently, and analysts remain optimistic about the stock’s prospects.

While Humana stock seems to be regaining momentum lately, it is still underperforming the broader market, keeping analysts cautiously optimistic about its prospects.

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.